News Bulletin
Monday, March 9th 2026
Morning Edition
Economic Numbers:
|
Time |
Event |
Forecast |
Previous |
|
10:00 |
|
105.06 |
|
|
11:00 |
|
3.10% |
|
|
11:30 |
|
3.61% |
|
|
11:30 |
|
3.54% |
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
DJIA |
47,501.55 |
49,116.08 |
46,331.95 |
|
NASDAQ |
22,387.68 |
23,189.20 |
22,086.97 |
|
S&P 500 |
6,740.02 |
6,902.28 |
6,582.48 |
Earnings Calendar:
(EPS: Earning Per Share / Rev: Revenue / Mkt Cap : market Capital/ BMO :
Before Market Opening /AMC : After Market Close)
|
EPS |
Consensus |
Previous |
Revenue |
Consensus |
Previous |
MarketCap |
Time |
|
Hewlett
Packard HPE:US |
0.53 |
0.49 |
9.87B |
7.85B |
$29.77B |
Q1 |
PM |
|
Casey's
General Stores CASY:US |
2.6 |
2.33 |
4.17B |
3.9B |
$20.91B |
Q3 |
PM |
|
Vail Resorts MTN:US |
6.67 |
6.56 |
1.15B |
1.14B |
$6.14B |
Q2 |
PM |
|
Korn Ferry International KFY:US |
1.23 |
1.19 |
692.35M |
676.5M |
$3.65B |
Q3 |
AM |
|
National
Beverage FIZZ:US |
0.46 |
0.42 |
279.07M |
267M |
$3.3B |
Q3 |
PM |
Market News:
U.S. stock futures fell sharply Monday as the
escalation in the Middle East conflict resulted in higher energy prices,
raising concerns about future economic growth.
Here are some of the biggest premarket U.S. stock
movers today:
Hims & Hers Health stock
surged 43% after Bloomberg reported that Novo Nordisk, up 1.1%, plans to sell
its weight-loss drugs through the telehealth
platform, marking a surprising reconciliation between the two companies after a
recent legal dispute.
Hewlett Packard
Enterprise stock fell 1.3% ahead of information technology company’s
first-quarter results, with expectations of around 19-20% year-over-year
revenue growth to roughly $9.3 billion, driven by AI infrastructure demand.
Pfizer stock dropped 1.6%
after the drugs giant announced results from a mid-stage clinical trial of its
experimental antibody treatment for atopic dermatitis.
Agilent Technologies
stock fell 1.4% after the life sciences firm said it will acquire privately
held clinical pathology firm Biocare Medical in an
all-cash deal valued at $950 million.
Aureus Greenway
stock jumped 47% higher after the Wall Street Journal reported that the holding
company will merge with Powerus, a drone manufacturer
backed by President Trump’s sons.
Relmada Therapeutics
stock surged 32% after the announcement of 12-month interim data from the
pharmaceutical company’s Phase 2 trial evaluating results in patients with
high-risk non-muscle invasive bladder cancer.
Exxon Mobil and Chevron both
gained around 1% as the oil majors benefited from the sharp move higher in
crude prices, as the Middle East conflict saw Brent trade above $110 a barrel.